Concepedia

Author

Dyana T. Saenz

Mayo ClinicORCID

Also Known As

D Saenz, D T Saenz, Dyana Saenz, Dyana T Saenz, Dyana T. Saenz, Dyana Terri Saenz

82

Publications

3K

Citations

29

H-Index

55

Concepts

All Affiliations

Mayo ClinicThe University of Texas MD Anderson Cancer CenterBaylor College of MedicineYale UniversityArvinas (United States)
DT

About

Dyana T. Saenz is an author at Mayo Clinic specializing in medicine, cell biology, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

17

1.6K

2

Engineering

2

2

74

3

Natural Sciences

2

2

93

4

Biochemistry

2

2

96

5

Biomedical Engineering

1

1

51

Dyana T. Saenz

×

33

Publications

2.9K

Citations

28

H-Index

YearCitations

An Essential Role for LEDGF/p75 in HIV Integration

Manuel Llano, Dyana T. Saenz, Anne M. Meehan,

Science

2006

523

LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes

Manuel Llano, Maria Vanegas, Oliver I. Fregoso,

Journal of Virology

2004

293

Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting

Heather Marshall, Keshet Ronen, Charles C. Berry,

PLoS ONE

2007

237

Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells

Dyana T. Saenz, Warren Fiskus, Yimin Qian,

Leukemia

2017

179

BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells

Baohua Sun, Warren Fiskus, Yimin Qian,

Leukemia

2017

167

Unintegrated Lentivirus DNA Persistence and Accessibility to Expression in Nondividing Cells: Analysis with Class I Integrase Mutants

Dyana T. Saenz, Nils A. Loewen, Mary Peretz,

Journal of Virology

2004

117

Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib

Baohua Sun, Bhavin Shah, Warren Fiskus,

Blood

2015

106

Restriction of Feline Immunodeficiency Virus by Ref1, Lv1, and Primate TRIM5α Proteins

Dyana T. Saenz, Wulin Teo, John C. Olsen,

Journal of Virology

2005

99

RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1

Christopher P. Mill, Warren Fiskus, Courtney D. DiNardo,

Blood

2019

96

BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells

Dyana T. Saenz, Warren Fiskus, Taghi Manshouri,

Leukemia

2016

89

Page 1